Jasper Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.19; its P/E ratio is -3.49; Jasper Therapeutics is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-1.18. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	$ -6.80M	$ 0.00
Gross Profit	-	-	-	$ -6.80M	-
EBIT	$ -17.59M	$ -15.97M	$ 13.63M	$ -12.93M	$ -12.71M
EBITDA	-	$ -15.59M	$ 14.01M	$ -12.56M	$ -12.44M
Net Income Common Stockholders	$ -17.54M	$ -16.08M	$ 13.63M	$ -13.21M	$ -11.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 103.87M	$ 115.80M	$ 129.40M	$ 38.25M	$ 50.95M
Total Assets	$ 110.41M	$ 124.16M	$ 138.76M	$ 48.36M	$ 59.11M
Total Debt	$ 3.01M	$ 3.23M	$ 3.44M	$ 3.65M	$ 3.85M
Net Debt	$ -100.85M	$ -112.57M	$ -125.95M	$ -34.60M	$ -47.10M
Total Liabilities	$ 16.27M	$ 13.96M	$ 13.56M	$ 12.37M	$ 11.54M
Stockholders Equity	$ 94.13M	$ 110.20M	$ 125.20M	$ 35.99M	$ 47.56M
Cash Flow	-
Free Cash Flow	-	$ -13.07M	$ -10.92M	$ -12.73M	$ -9.87M
Operating Cash Flow	$ -11.65M	$ -13.06M	$ -10.89M	$ -12.65M	$ -9.64M
Investing Cash Flow	-	$ -11.00K	$ -26.00K	$ -82.00K	$ -222.00K
Financing Cash Flow	$ -308.00K	$ -725.00K	$ 102.28M	$ 28.00K	$ 1.00K

Currency in USD

Jasper Therapeutics Earnings and Revenue History

Income Statement >

Jasper Therapeutics Debt to Assets

Balance Sheet >

Jasper Therapeutics Cash Flow

Cash Flow >

Jasper Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing